159 related articles for article (PubMed ID: 3259931)
1. Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonists.
Braun AR; Chase TN
Eur J Pharmacol; 1988 Mar; 147(3):441-51. PubMed ID: 3259931
[TBL] [Abstract][Full Text] [Related]
2. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
Koller WC; Herbster G
Clin Neuropharmacol; 1988 Jun; 11(3):221-31. PubMed ID: 3261198
[TBL] [Abstract][Full Text] [Related]
3. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
Carlson JH; Bergstrom DA; Demo SD; Walters JR
Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
[TBL] [Abstract][Full Text] [Related]
4. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
Braun AR; Chase TN
Eur J Pharmacol; 1986 Nov; 131(2-3):301-6. PubMed ID: 3493161
[TBL] [Abstract][Full Text] [Related]
5. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
6. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
Morelli M; Fenu S; Di Chiara G
Life Sci; 1987 Jan; 40(3):245-51. PubMed ID: 2948094
[TBL] [Abstract][Full Text] [Related]
7. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
Meller E; Bordi F; Bohmaker K
Life Sci; 1988; 42(25):2561-7. PubMed ID: 3260320
[TBL] [Abstract][Full Text] [Related]
8. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
Vasse M; Chagraoui A; Protais P
Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
[TBL] [Abstract][Full Text] [Related]
9. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation.
Pifl C; Hornykiewicz O
Eur J Pharmacol; 1988 Jan; 146(1):189-91. PubMed ID: 3258244
[No Abstract] [Full Text] [Related]
10. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
11. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
12. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.
Gandolfi O; Dall'olio R; Vaccheri A; Roncada P; Montanaro N
Pharmacol Biochem Behav; 1988 Jun; 30(2):463-9. PubMed ID: 3262877
[TBL] [Abstract][Full Text] [Related]
13. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
Longoni R; Spina L; Di Chiara G
Life Sci; 1987 Nov; 41(18):2135-45. PubMed ID: 2959833
[TBL] [Abstract][Full Text] [Related]
14. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
Arnt J; Bøgesø KP; Hyttel J; Meier E
Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
Cunningham KA; Callahan PM; Appel JB
Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
[TBL] [Abstract][Full Text] [Related]
16. Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol.
Lublin H; Gerlach J
Eur J Pharmacol; 1988 Aug; 153(2-3):239-45. PubMed ID: 3263277
[TBL] [Abstract][Full Text] [Related]
17. Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade.
Barone P; Tucci I; Parashos SA; Chase TN
Eur J Pharmacol; 1988 May; 149(3):225-32. PubMed ID: 3261693
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
Ongini E; Caporali MG
Neuropharmacology; 1987 Apr; 26(4):355-60. PubMed ID: 2953987
[TBL] [Abstract][Full Text] [Related]
19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
20. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
Arnt J; Hyttel J
Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
